Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 37-48 of 2,031
Behavioral study icon
RecruitingNCT07009223

Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice

This study is looking at whether questionnaires and follow-up can help people with depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Brescia
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 50 Years to 80 Years
Countries
Italy
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Condition
Depression
Other study type icon
RecruitingISRCTN10469580

Lifestyle physical activity counselling for in-people with major depressive disorder

This study is looking at whether a digital support tool can help people with Depression or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In Switzerland
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Swiss National Science Foundation
Condition
Depression
Other study type icon
RecruitingNCT07633080

Magnesium Bisglycinate in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Bhubaneswar
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Depression
Behavioral study icon
RecruitingNCT03973268

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in people with Treatment-Resistant Major Depression

This study is looking at whether a digital support tool can help people with Depression or Major Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Bethesda
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Other study type icon
RecruitingNCT06746155

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Calgary
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Abraham Nunes
Condition
Depression
Drug study icon
RecruitingISRCTN10974027

Safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of intravenous dosing of SPL026 drug product (N, N-dimethyltryptamine fumarate; DMT Fumarate [A Serotonergic Psychedelic]) alone or in combination with selective serotonin reuptake inhibitors in people with major depressive disorder

This study is recruiting in the United Kingdom. It focuses on depression.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 99 Years
Countries
United Kingdom
Sponsor
Cybin UK Ltd
Condition
Depression
Other study type icon
RecruitingNCT07592689

Study of DT120 for Major Depressive Disorder (Ascend)

This study is recruiting in the United States. It focuses on depression.

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Drug study icon
RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom
Sponsor
Alto Neuroscience
Condition
Depression
Device study icon
RecruitingNCT04041479

Biomarker-guided rTMS for Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or depression. Participants take part in a digital support tool and complete follow-up assessments.

Multiple locations, including Stanford
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.